Does BOTULINUM TOXIN TYPE A Cause Obesity? 413 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 413 reports of Obesity have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 11.0% of all adverse event reports for BOTULINUM TOXIN TYPE A.
413
Reports of Obesity with BOTULINUM TOXIN TYPE A
11.0%
of all BOTULINUM TOXIN TYPE A reports
412
Deaths
337
Hospitalizations
How Dangerous Is Obesity From BOTULINUM TOXIN TYPE A?
Of the 413 reports, 412 (99.8%) resulted in death, 337 (81.6%) required hospitalization, and 344 (83.3%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 413 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Obesity Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE